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The Center for Medical Genomics (CMG) provides Indiana researchers with next-generation 
sequencing, SNP genotyping, gene expression and epigenetics. We provide expertise in 
experimental design, carry out the procedures, and assist with analyses and interpretation. These 
state-of-the-art technologies have enabled a large number of grants to be funded over the years, 
and have resulted in a very large number of publications. 
Our next-generation sequencing technology includes SOLiD5500xl, Ion Proton and Ion Torrent 
PGM (Personal Genome Machine). This set of instruments covers a wide range of next-
generation sequencing capabilities from small bacterial genomes to the whole human genome, 
transcriptome (total RNA), small RNA, targeted DNA fragments, exome, ChIP-seq, and methyl-
seq. We have generated sequencing data for 52 projects over the past two years. 
Our SNP genotyping facility, using the Sequenom MassArray platform, specializes in targeted 
genotyping of 20-30 SNPs per assay and is an excellent choice for candidate gene studies and for 
following up results from GWAS and next-generation sequencing. It has been a central part of 
several large, multi-site collaborative genetic studies, including Genetics of Alcoholism 
(COGA), bipolar disorder, osteoporosis and hypertension, as well as many smaller projects; it is 
most efficient for sets of approximately 370 samples. We have produced more than 20 million 
targeted SNP genotypes to date. This platform is also capable of measuring allele-specific gene 
expression, and targeted quantitative DNA methylation for epigenetics study.  
For many projects, microarrays offer a good alternative to next-generation sequencing for 
measuring gene expression. We use Affymetrix GeneChip microarrays, capable of measuring 
expression of nearly all genes in humans (and all exons within them), rats, mice and most model 
organisms, and can measure expression of miRNAs. We can also use RNA extracted from FFPE 
samples. We have carried out more than 6,700 GeneChip hybridizations to date in support of 
many different projects. 
The CMG partners with the Center for Computational Biology and Bioinformatics for data 
analysis. We are recognized as a Core Facility of the Indiana CTSI and available to faculty not 
only from IU and IUPUI, but also from Purdue and Notre Dame Universities. 
 
 
